Medicalization of Cannabis

Medicalization is the process by which human conditions and problems come to be defined and treated as medical conditions, and thus become the subject of medical study, diagnosis, prevention, or treatment. Medicalization can be driven by new evidence or hypotheses about conditions; by changing social attitudes or economic considerations; or by the development of new medications or treatments.

So now that we know what medicalization is, why is it so important and why is it so relevant to cannabis and to what CannabiMatch is looking to achieve with its R&D efforts in the cannabis industry?

There has been extensive historical anecdotal evidence of the efficacy of cannabinoids in treating a range of medical conditions. Some of this anecdotal evidence has started to be empirically proven; however, there is still a long journey between taking anecdotal observations, proving them scientifically, and then generating products that reduce human suffering. That’s where CannabiMatch steps in.

Although the regulatory environment and attitude to cannabis in many countries have now changed, our knowledge of the powers of cannabinoids is still in its infancy. The potential to unlock the healing powers of cannabinoids has never been greater.

This means that cannabinoids may have a significant role not only in applications where cannabinoids have proven their effectiveness in alleviating symptoms and conditions, such as chronic pain, dermatology, CNS disorders and oncology, but also in fields of health that require attention but have no effective treatment options.

We believe that CannabiMatch’s unique, inclusionary business model, which is based on partnerships, not competition, with pharma, life science and biotech firms, is the optimal way to bring scientifically proven cannabinoids-based products to the market for the benefit of the unhealthy.

Is it possible that the silver bullet for so many afflictions has been under our noses for millennia? CannabiMatch believes it has and will utilize its human capital and partnerships to prove it.